Albright to Lead Nexell Therapeutics

Nexell Therapeutics Inc. said Wednesday that William A. Albright Jr. has been named president and chief operating officer of the Irvine medical company.

Albright replaces L. William McIntosh, who will leave the management team but continue to advise the company as a consultant and a director.

Albright had been Nexell’s senior vice president and chief financial officer. The company develops cell therapies and diagnostics for cancer, autoimmune, metabolic and genetic diseases.